Episode summary
BI Weekend: Nvidia, Retail Earnings Results | Bloomberg Intelligence
Summary
Nvidia’s quarter was presented as strong but not flawless: the chip giant beat expectations, yet its softer revenue outlook reignited worries that AI infrastructure spending could be cooling. Bloomberg Intelligence’s semiconductor analyst said the results still looked like a “solid sprint and guide,” pointing to a meaningful networking beat, Blackwell-related strength, and guidance that would have looked even better if China had been included. China remained a key overhang, with the analyst saying clarity on export rules and a Blackwell-specific China chip will be needed before that revenue can ramp materially.
The discussion then turned to dealmaking, where Bloomberg Intelligence argued that the Trump-era regulatory backdrop is improving the odds for large mergers. The Nexstar-Tegna transaction was framed as likely to clear the FCC, while the broader view was that the DOJ and FTC are now more willing to settle problematic deals rather than block them outright. That same deal-friendly backdrop also shaped views on AT&T’s roughly $23 billion purchase of EchoStar spectrum licenses, which was described as a major relief for EchoStar’s balance sheet and a strategically valuable boost to AT&T’s network.
On the consumer side, Keurig Dr Pepper’s planned JDE Peet’s acquisition was framed as a way to fix a struggling coffee business, while Eli Lilly’s obesity-pill trial added another positive read for the company’s pipeline. William Sonoma, Kohl’s, and Abercrombie all showed signs of resilient demand, though tariffs, vendor pressure, and uneven category performance remain major watch points.
Key takeaways
- Nvidia’s results beat, but the analyst said China uncertainty and a cautious revenue guide kept investor enthusiasm in check.
- The analyst expects the FCC to approve Nexstar’s Tegna deal because broadcast-ownership rules are being rewritten or vacated.
- AT&T’s $23 billion EchoStar spectrum purchase was described as strategically worth it because spectrum value rises over time and boosts network quality.
- Keurig Dr Pepper’s JDE Peet’s deal is meant to shore up coffee, which the analyst said is being squeezed by higher bean costs and tariffs.
- Eli Lilly’s obesity-pill trial showed about 10% weight loss in diabetic obese patients, which the analyst said supports likely approval.
- Williams Sonoma, Kohl’s, and Abercrombie all showed consumer resilience, but tariffs and selective pricing remain key margin issues.
Notable quotes
“it checked all the fundamental key boxes but as has been the case with this name you know the expectations always run higher”
“the company did guide to a 2 to 5 billion revenues from the H20 in China next quarter which is positive”
“I think in the end, yes, because the timing was right”
“This two-step deal basically addresses um a lagging division they've had”
“This is a a drug that's likely to get approved”
How the episode opens
Bloomberg Audio Studios podcasts radio news. This is Bloomberg Intelligence with Paul Sweeney. — The real our performance has been the US corporate high yield. These are two big time blue chip companies. One person's chaos is another person's animal spirits.
Breaking market headlines and corporate news from across the globe. — Our view is that the economy is slowing down. There is the possibility of a death spiral. — Both quantum computing and AI are going to power the future. — People are just buying everything with tech.
Bloomberg Intelligence with Paul Sweeney on Bloomberg Radio, YouTube, and Bloomberg Originals. — I'm Paul Sweeney. — And I'm Scarlett Fu filling in on Bloomberg Intelligence. — On today's Bloomberg Intelligence Show, we dig inside the big business stories impacting Wall Street and the global markets.
Each and every week, we provide in-depth research and data on some of the 2,000 companies and 130 industries our analysts cover worldwide. Today we'll take a look at how the beverage maker Kurig Dr. Peppers looking to strengthen its struggling coffee business.
Plus, Echoar agrees to sell Spectrum licenses to AT&T. We'll discuss what the deal means for the telecommunications companies. — But first, we begin with earnings from the chip giant Nvidia. This week, the world's most valuable publicly traded company reported second quarter earnings that beat analyst expectations.
But investors were disappointed after Nvidia gave a lukewarm revenue forecast for the current quarter. And this is fueling concerns. A massive runup in artificial intelligence spending is slowing. — For more, Scarlet and I were joined by Kujan Sabani, Bloomberg Intelligence senior semiconductor analyst. We first asked Kunjan for his take on Nvidia's results.
Yeah, like you said, it was once again a solid sprint and guide.
From the episode’s captions: roughly the first two minutes, lightly cleaned. Keep watching on YouTube →
Topics
- nvidia earnings
- retail earnings
- media merger antitrust
- consumer acquisition deal
- obesity drug trial
Companies and tickers mentioned
- NVDA
- NXST
- KDP
- LLY
- WSM
- T
- SATS
- KSS
- ANF
- Nvidia
- Nexstar
- Tegna
- Keurig Dr Pepper
- JDE Peet’s
- Eli Lilly
- Williams Sonoma
- AT&T
- EchoStar
- Kohl's
- Abercrombie & Fitch
- Bloomberg L.P.
Watch the episode
Watch “BI Weekend: Nvidia, Retail Earnings Results | Bloomberg Intelligence” on YouTube
Summary, takeaways and quote selection by Octagon. Quotes are short excerpts; the full conversation is in the episode.
More from Bloomberg Intelligence
-
Instant Reaction: Nvidia CEO Jensen Huang Ousted by Nvidia Board | Bloomberg Intelligence -
Nvidia’s Huang Ousted by Board in Move That Roils AI Economy | Bloomberg Intelligence -
CoreWeave Shares Soar After AI Computing Firm Eases Debt Fears | Bloomberg Intelligence -
Anthropic Targets $1.4 Trillion Valuation in Blockbuster IPO | Bloomberg Intelligence -
Nvidia Probe Into CEO Affair Raises Thorny Questions for AI | Bloomberg Intelligence -
Election 'Blue Wave' & Your Wallet; Navigating AI-Driven Market Volatility | Bloomberg Intelligence
Bloomberg Intelligence, this episode and its artwork belong to Bloomberg. Octagon is not affiliated with the show; this page is an independent summary.